Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers

Plastic and Reconstructive Surgery

Volumn 117, Issue 7 SUPPL., 2006, Pages

  Mustoe, Thomas A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR;

BACTERIAL COUNT; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; LEG ULCER; NONHUMAN; NOTE; PRIORITY JOURNAL; WOUND CARE;

EID: 33748274313     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000222529.21078.76     Document Type: Note

References (5)

1. Mustoe, T. A., Pierce, G. F., Thomason, A., Sporn, M., Gramates, P. H., and Deuel, T. F. Accelerated healing of incisional wounds in rats induced by transforming growth factor-B. Science 237: 1333, 1987.
2. Cross, K. C., and Mustoe, T. A. Growth factors in wound healing. Surg. Clin. North Am. 83: 531, 2003.
3. Wu, S. C., and Armstrong, D. G. The role of activity, adherence, and offloading on the healing of diabetic foot wounds. Plast. Reconstr. Surg. 117 (Suppl.): 248S, 2006.
4. Mustoe, T. A., O'Shaughnessy, K., and Kloeters, O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast. Reconstr. Surg. 117 (Suppl.): 35S, 2006.
5. Mogford, J. E., Liu, W. R., Said, H., et al. Adenoviral hTERT improves ischemic wound in an aged rabbit model. Hum. Gene Ther. (in press).